Issue 1-22, 2023

https://doi.org/10.38025/2078-1962-2023-22-1-46-59

Methodological Problems of Psychometric Tests in Clinical Studies of Cognitive Disorders in Patients with Cerebral Vascular Lesions: a Review

View article (Download PDF file)



Download XML file

1 ORCIDAlina D. Aizenshtein, 1 ORCIDAleksandra K. Trofimova, 1,2,3 ORCIDYuri V. Mikadze, 1,3 ORCIDGalina E. Ivanova

1 Federal Center of Brain and Neurotechnologies, Moscow, Russian Federation
2 Lomonosov Moscow State University, Moscow, Russian Federation
3 Pirogov Russian National Research Medical University, Moscow, Russian Federation


ABSTRACT

AIM. To assess cognitive dysfunction in clinical practice, depending on the task being solved in the examination, different neuropsychological research methods are used. To identify the specific cause of the dysfunctions in the structure of various mental functions (neuropsychological characteristics of the defect) and in the brain functions (topical diagnosis), methods of qualitative analysis of the detected symptoms of the disorder are used. Psychometric (quantitative) methods are used to assess numerically the severity of disorders and the dynamics of changes in the state of individual mental functions, as well as for screening assessment of e possible cognitive decline level in general. Methods of cognitive dysfunctions qualitative assessment are focused on the search for a «missing link» in the structure of the examined mental functions. Psychometric tests, in most cases, describe the general state of either individual mental functions, or, in the case of screening, a set of cognitive functions. Thus, one or more aspects of mental functions are evaluated, in which several cognitive functions are involved at once.
The article presents the results of a literature review with a description and analysis of preferences, methods used and corresponding techniques for neuropsychological examination of cognitive disorders in domestic clinical practice in vascular brain lesions.


KEYWORDS: cognition, HMF, HMF disorders, cognitive dysfunction; neuropsychological tests, psychometric test, screening tests, stroke, brain lesions

FOR CITATION: Aizenshtein A.D., Trofimova A.K., Mikadze Y.V., Ivanova G.E. Methodological Problems of Psychometric Tests in Clinical Studies of Cognitive Disorders in Patients with Cerebral Vascular Lesions: a Review. Bulletin of Rehabilitation Medicine. 2023; 22(1): 46-59. https://doi.org/10.38025/2078-1962-2023-22-1-46-59

FOR CORRESPONDENCE: Alina D. Aizenshtein, E-mail: alinaaiz@yandex.ru


References:

  1. Luriya A.R. Osnovy` nejropsixologii: uchebnoe posobie dlya studentov vy`sshix uchebny`x zavedenij. Moscow. Izdatel`stvo centr “Akademiya”. 2002 (In Russ.).
  2. Zaxarov V.V., Yaxno N.N. Kognitivny`e rasstrojstva v pozhilom i starcheskom vozraste. Metodicheskoe posobie dlya vrachej. Moscow. 2005: (71). (In Russ.).
  3. Mikadze Yu.V. Metodologicheskie tendencii v sovremennom razvitii nejropsixologicheskoj diagnostiki. V kn.: Modern directions of diagnostics in clinical (medical) psychology Collective monograph. Red. Zvereva N.N., Roshhina I.F. Moscow. OOO “Sam Poligrafist”. 2021: 44–54. (In Russ.).
  4. Mikadze Y.V., Ardila A., Akhutina T.V. A.R. Luria’s Approach to Neuropsychological Assessment and Rehabilitation. Archives of Clinical Neuropsychology. 2019; 34(6): 795–802. https://doi.org/10.1093/arclin/acy095
  5. Petersen R.S., Smith G.E., Waring S.C. et al. Mild cognitive impairment: clinical characterization and outcome. Archives of Neurology. 1999; (56): 303–8.
  6. Petersen R., Negash S. Mild Cognitive Impairment: An Overview. CNS Spectrums. 2008; 13(1): 45–53. https://doi.org/10.1017/S1092852900016151
  7. Gavrilova S.I. Psixicheskie rasstrojstva pri pervichny`x degenerativny`x (atroficheskix) processax golovnogo mozga. Rukovodstvo po psixiatrii. Pod red. A.S. Tiganova. Moscow. 1999: (2). (In Russ.).
  8. Zaxarov V.V., Vaxnina N.V. Kognitivny`e narusheniya pri arterial`noj gipertenzii. Nervny`e bolezni. 2013; (3). (In Rus.).
  9. Grishina D.A., Lokshina A.B. Diagnosis and treatment of vascular cognitive impairments. Meditsinskiy sovet = Medical Council. 2021; (2): 45–54. https://doi.org/10.21518/2079–701X-2021–2-45–54 (In Russ.).
  10. Ivanets N.N., Avdeeva T.I. Psychometric scales in diagnosis of late-onset affective disorders: the current status of the problem and possible solution paths. Russian Journal of Psychiatry. 2012: (1). (In Russ.).
  11. Davis D.H.J., Creavin S.T., Noel-Storr A. et al. Neuropsychological tests for the diagnosis of Alzheimer’s disease dementia and other dementias: a generic protocol for cross-sectional and delayed-verification studies. Cochrane Database of Systematic Reviews. 2013; (3). https://doi.org/10.1002/14651858.CD010460
  12. Davis D.H.J., Creavin, S.T., Yip J.L. et al. Montreal Cognitive Assessment for the detection of dementia. Cochrane Database of Systematic Reviews. 2021; (7): CD010775. https://doi.org/10.1002/14651858.CD010775
  13. O’Brien J., Ames D., Gustafson L. et al. Cerebrovascular disease, cognitive impairment and dementia. CRC Press. 2004.
  14. Gorelick P.B., Scuteri A., Black S.E. et al. Vascular Contributions to Cognitive Impairment and Dementia: A Statement for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke. 2011; 42(9): 2672–713. https://doi.org/10.1161/STR.0b013e3182299496
  15. Iakhno N.N. E.I. Gusev, A.N. Bogolepova. Cognitive disorders in cerebrovascular diseases. M: MEDpressinform 2012; 160. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2013; 113(4): 95-95 (In Russ.).
  16. Jaillard A., Naegele B., Trabucco-Miguel S. et al. Hidden dysfunctioning in subacute stroke. Stroke. 2009; 40(7): 2473–2479.
  17. Nys G.M.S., van Zandvoort M.J.E., de Kort P.L.M. et al. Cognitive disorders in acute stroke: prevalence and clinical determinants. Cerebrovascular Diseases. 2007; 23(5–6): 408–416.
  18. Jacquin A., Binquet C., Rouaud O. et al. Poststroke cognitive impairment: high prevalence and determining factors in a cohort of mild stroke. Journal of Alzheimer’s Disease. 2014; 40(4): 1029–38. https://doi.org/10.3233/JAD-131580
  19. Sun J.H, Tan L., Yu J.T. Post-stroke cognitive impairment: epidemiology, mechanisms and management. Annals of translational medicine. 2014; 2(8): 80. https://doi.org/10.3978/j.issn.2305–5839.2014.08.05
  20. Delavaran H., Jonsson A.C., Lovkvist H., et al. Cognitive function in stroke survivors: a 10-year follow-up study. Acta Neurologica Scandinavica. 2017; 136(3): 187–194. https://doi.org/10.1111/ane.12709
  21. Lyukmanov R.Kh., Aziatskaya G.A., Varako N.A., Koviazina M.S., Suponeva N.A., Chernikova L.A., Frolov A.A., Piradov M.A. Post-stroke rehabilitation training with a brain-computer interface: a clinical and neuropsychological study. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2018; 118(8): 43-51. https://doi.org/10.17116/jnevro201811808143 (In Russ.).
  22. Akhutina T.V., Melikyan Z.A. Neuropsychological Assessment: an overview of modern tendencies (dedicated to 110-th anniversary of A.R. Luria). Clinical Psychology and Special Education. 2012; V.1(2). (In Russ.).
  23. Muxangalieva D.G., Turuspekova S.T. Application of screening scales in neuropsychological testing: opportunities and limitations. Vestnik Kazaxskogo Nacional`nogo medicinskogo universiteta. 2020; (1): 229–233 (In Russ.).
  24. Kovalenko E.A., Bogolepova A.N. Pre-stroke cognitive impairment and its impact on medication adherence. Neurology, Neuropsychiatry, Psychosomatics. 2018; 10(2): 63–67. https://doi.org/10.14412/2074–2711–2018–2-63–67 (In Russ.).
  25. Verbitskaya S.V., Parfenov V.A., Reshetnikov V.A., Kozlov V.V., Kabaeva A.R. Post-stroke cognitive impairment (results of a 5-year follow-up). Neurology, Neuropsychiatry, Psychosomatics. 2018; 10(1): 37–42. https://doi.org/10.14412/2074–2711–2018–1-37–42 (In Russ.).
  26. Reznikova T.N., Seliverstova N.A., Chikhachev I.V. Correction of Cognitive and Emotional-Personal Processes Modification in Elderly Persons in a Non-Medicamentous Way (Method of Artificial Stable Functional Brain Connections). Clinical Psychology and Special Education. 2021; 10(4): 162–184. https://doi.org/10.17759/cpse.2021100408 (In Russ.).
  27. Naumenko A.A., Preobrazhenskaya I.S. Cognitive and motor training for patients with moderate cognitive impairment and mild dementia. Neurology, Neuropsychiatry, Psychosomatics. 2018; 10(4): 81–87. https://doi.org/10.14412/2074–2711–2018–4-81–87 (In Russ.).
  28. Gromova E.A., Kataeva G.V., Khomenko I.G., Kotomin I.A., Bogdan A.A., Kosych A.V., Rassokhin V.V., Belyakov N.A., Trofimova T.N. Psychic State and Cognitive Function in HIV-infected Patients and Functional State of the Brain Structures (According to Positron Emission Tomography and Magnetic Resonance Spectroscopy). Clinical Psychology and Special Education. 2020; 9(1): 78–103. https://doi.org/10.17759/cpse.2020090105 (In Russ.).
  29. Fantalis D., Preobrazhenskaya I.S. Cognitive, emotional and motor disorders and their impact on the postoperative rehabilitation of neurosurgical patients. Neurology, Neuropsychiatry, Psychosomatics. 2021; 13(6): 35–40. https://doi.org/10.14412/2074–2711–2021–6-35–40 (In Russ.).
  30. Yakhno N.N., Koberskaya N.N., Perepelov V.A., Smirnov D.S., Solodovnikov V.I., Trufanov M.I., Gridin V.N. Hippocampal magnetic resonance imaging morphometry and neuropsychological parameters in patients with Alzheimer’s disease. Neurology, Neuropsychiatry, Psychosomatics. 2019; 11(4): 28–32. https://doi.org/10.14412/2074–2711–2019–4-28–32 (In Russ.).
  31. Voskresenskaya O.N., Zakharova N.B., Tarasova Yu.S., Tereshkina N.E., Perepelov V.A., Perepelova E.M. Possible mechanisms of cognitive dysfunction in patients with chronic forms of cerebrovascular diseases. Neurology, Neuropsychiatry, Psychosomatics. 2018; 10(1): 32–36. https://doi.org/10.14412/2074–2711–2018–1-32–36 (In Russ.).
  32. Koberskaya N.N., Ostroumova T.M., Perepelov V.A., Smirnov D.S. Influence of genetic and comorbid emotional-affective factors on pre-mild cognitive decline in middle-aged patients. Neurology, Neuropsychiatry, Psychosomatics. 2021; 13(4): 66–74. https://doi.org/10.14412/2074–2711–2021–4-66–74 (In Russ.).
  33. Esina E.Yu., Zujkova A.A., Ostroushko N.I., Cherkashenko T.A., Nekhaenko N.E., Posmet’eva O.S., Kotova Yu.A., Shevcova V.I., Shcherbakova N.G., Dobrynina I.S., Strahova N.V., Krasnoruckaya O.N., Muravickaya M.N., Hanina E.A. Mini-cog test and MMSE scale in screening of cognitive disorders in elderly and senior people in a practice of a primary health doctor. Profilakticheskaya Meditsina. 2020; 23(5): 105-110. https://doi.org/10.17116/profmed202023051105 (In Russ.).
  34. Lokshina A.B., Grishina D.A., Prevention of cognitive impairment in patients with cerebrovascular disease. Profilakticheskaya Meditsina. 2019; 22(2): 89-94. https://doi.org/10.17116/profmed20192202189 (In Russ.).
  35. Tolmacheva V.A., Grishina D.A., Romanov D.V. Cognitive impairment and mental disorders in patients with focal muscular dystonia. Neurology, Neuropsychiatry, Psychosomatics. 2019; 11(4): 51-56. https://doi.org/10.14412/2074-2711-2019-4-51-56 (In Russ.).
  36. Novikova I.A., Solov`ev A.G., Popov V.V. Cognitive and affective disorders in the elderly. Advances in Gerontology. 2017; 30(3): 442-449 (In Russ.).
  37. Mineev K.K., Petrov A.M., Votintseva M.V., Stolyarov I.D. The correlation between motor and cognitive dysfunction in multiple sclerosis. Annals of clinical and experimental neurology 2020; 14(4): 23-28. https://doi.org/10.25692/ACEN.2020.4.3 (In Russ.).
  38. Galkin S.A., Peshkovskaya A.G., Kisel N.I., Vasilieva S.N., Ivanova S.A., Bokhan N.A. Cognitive Changes in Comorbidity Alcohol Dependence and Affective Disorders. Psikhiatriya. 2020; 18(3): 42-48. https://doi.org/10.30629/2618-6667-2020-18-3-42-48 (In Russ.).
  39. Samoĭlova Iu.G., Rotkank M.A., Kudlay D.A., Zhukova N.G., Matveeva M.V., Tolmachev I.V. A prognostic model of cognitive impairment in patients with type 1 diabetes mellitus. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2020; 120(3): 19-22. https://doi.org/10.17116/jnevro202012003119 (In Russ.).
  40. Zhilyaeva T.V., Blagonravova A.S., Mazo G.E. The effect of various forms of folates on cognitive functions in patients with chronic schizophrenia. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2020; 120(9): 87-92. https://doi.org/10.17116/jnevro202012009187 (In Russ.).
  41. Pizova N.V., Bykanova M.A., Kurapin E.V. Clinical, neuropsychological and epidemiological aspects of the «transitional» form of Parkinson’s disease in the Yaroslavl region. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2019; 119(4): 66-71. https://doi.org/10.17116/jnevro201911904166 (In Russ.).
  42. Ostapchuk E.S., Myakotny`x V.S., Borovkova T.A. The formation and dynamics of cognitive disordersin acute period of stroke in representatives different ages. Advances in Gerontology. 2017; 30(6): 893-900 (In Russ.).
  43. Pozhidaev K.A., Parfenov V.A. Cognitive and emotional impairment in patients with migraine and signs of leukoencephalopathy during preventive therapy. Neurology, Neuropsychiatry, Psychosomatics. 2020; 12(6): 19-25. https://doi.org/10.14412/2074-2711-2020-6-19-25 (In Russ.).
  44. Chutko L.S., Surushkina S.Yu., Iakovenko E.A., Anisimova T.I., Karpovskaya E.B., Vasilenko V.V., Didur M.D., Volov M.B. Impairments of cognitive control in patients with somatoform disorders and their treatment. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2019; 119(4): 32-37. https://doi.org/10.17116/jnevro201911904132 (In Russ.).
  45. Homenko Ju.G., Kataeva G.V., Bogdan A.A., Chernysheva E.M., Susin D.S. Cerebral metabolism in patients with cognitive disorders: a combined MRS and PET study. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2019; 119(1): 51-58. https://doi.org/10.17116/jnevro201911901151 (In Russ.).
  46. Bogolepova A.N., Makhnovich E.V., Jyravleva A.N. The relationship between cognitive impairment and changes in retinal neuroarchitectonics. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2020; 120(9): 7-13. https://doi.org/10.17116/jnevro20201200917 (In Russ.).
  47. Zhavoronkova L.A., Maksakova O.A., Shevtsova T.P., Moraresku S.I., Kuptsova S.V., Kushnir E.M., Iksanova E.M. Dual-tasks is an indicator of cognitive deficit specificity in patients after traumatic brain injury. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2019; 119(8): 46-52. https://doi.org/10.17116/jnevro201911908146 (In Russ.).
  48. Teregulova D.R., Bakirov B.A., Akhmadeeva L.R. An impact of affective and cognitive impairment on the quality of life in patients with lymphoproliferative diseases. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2019; 119(4): 5-8. https://doi.org/10.17116/jnevro20191190415 (In Russ.).
  49. Avrov M.V., Alifirova V.M., Kovalenko A.V. An effect of complex therapy on cognitive impairment in patients with chronic cerebral ischemia. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2019; 119(2): 23-27. https://doi.org/10.17116/jnevro201911902123 (In Russ.).
  50. Chepelyuk A.A., Vinogradova M.G., Kovalenok T.V., Dorofeeva O.A., Metlina M.V., Neznamov G.G. Cognitive processes in patients with different structure of anxiety disorders. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2018; 118(3): 4-9. https://doi.org/10.17116/jnevro2018118314-9 (In Russ.).
  51. Chernenkaya V.Yu., Gorbachev K.V., Gorbachev D.V., Ataulina A.I., Fominykh V.V., Brylev L.V., Gekht1 A.B. The Edinburgh Cognitive and Behavioral ALS Screen (ECAS): a Russian version. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2018; 118(12): 36-39. https://doi.org/10.17116/jnevro201811812136 (In Russ.).
  52. Buleyko A.A., Soldatkin V.A., Murina I.V., Ruban D.A., Simak O.Ya., Krysenko P.B., Kryuchkova M.N. Does alcohol influence the cognitive functions of schizophrenic patients? Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2019; 119(7): 14-19. https://doi.org/10.17116/jnevro201911907114 (In Russ.).
  53. Parfenov V.A., Ostroumova T.M., Ostroumova O.D., Borisova E.V., Perepelov V.A., Perepelova E.M. Cognitive functions, emotional status, MRI measurements in treatment-naïve middle-aged patients with uncomplicated essential arterial hypertension. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2018; 118(8): 23-32. https://doi.org/10.17116/jnevro201811808123 (In Russ.).
  54. Matveeva M.V., Samoĭlova Iu.G., Zhukova N.G., Ratkina K.R., Yakimovich I.Yu. Different types of cognitive rehabilitation in patients with type 2 diabetes. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2019; 119(8): 12-17. https://doi.org/10.17116/jnevro201911908112 (In Russ.).
  55. Zueva I.B., Krivonosov D.S., Buch A.V., Kim Yu.V. Cognitive impairment in patients with metabolic syndrome. The current treatment possibilities. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2018; 118(5): 18-22. https://doi.org/10.17116/jnevro20181185118 (In Russ.).
  56. Parfenov V.A., Zhivolupov S.A., Nikulina K.V., Poverennova I.E., Lapatuhin V.G., Zhestikova M.G., Zhukova N.G., Glazunov A.B. Diagnosis and treatment of cognitive impairment in patients with chronic cerebral ischemia: the results of observational Russian program DIAMANT. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2018; 118(6): 15-23. https://doi.org/10.17116/jnevro20181186115 (In Russ.).
  57. Selezneva N.D., Roshchina I.F., Korovaĭtseva G.I., Gavrilova S.I. Prevention of progression of cognitive decline in the first-degree relatives of patients with Alzheimer’s disease. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2018; 118(10): 30-36. https://doi.org/10.17116/jnevro201811810130 (In Russ.).
  58. Fedin A.I.The efficacy of cortexin and memantinol (memantine) in the treatment of cognitive impairment in patients with chronic cerebral ischemia. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2018; 118(1): 30-36. https://doi.org/10.17116/jnevro20181181130-36 (In Russ.).
  59. Shi D., Chen X., Li Z. Diagnostic test accuracy of the Montreal Cognitive Assessment in the detection of post-stroke cognitive impairment under different stages and cutoffs: a systematic review and meta-analysis. Neurological Sciences. 2018; 39(4): 705- 716. https://doi.org/10.1007/s10072-018-3254-0
  60. Rist P.M., Chalmers J., Arima H., et al. Baseline cognitive function, recurrent stroke, and risk of dementia in patients with stroke. Stroke. 2013; (44): 1790-1795.




Creative Commons License
The content is available under the Creative Commons Attribution 4.0 License.

©


This is an open article under the CC BY 4.0 license. Published by the National Medical Research Center for Rehabilitation and Balneology.